Key Findings
- Pooled LDL reduction was 0.33 mmol/L (95% CI: 0.27–0.38 mmol/L lower).
- Non-HDL cholesterol fell by 0.39 mmol/L (95% CI: 0.27–0.50 mmol/L lower).
- Apolipoprotein B fell by 0.05 g/L (95% CI: 0.03–0.08 g/L lower).
- The review graded LDL and non-HDL evidence moderate because results varied across studies; apoB evidence was high.
- Included trials lasted at least three weeks. The median studied dose does not establish one optimal regimen.